Some on the news initiatives expected on the ballot for November's upcoming special election.
Nancy Vogel in the LA Times reports that supporters and opponents of the redistricting measure--which was thrown off the ballot because the version submitted to the Attorney General was different that the version the voters signed--argued in court about whether it would be reinstated on the ballot. Who knows? The Supreme Court knows. And we will soon enough.
Jennifer Warren in the LA Times reports that supporters and opponents of the anti-choice measure requiring parental notification of abortion also met in court and argued about voter pamphlet language. Interesting note in her story that this measure is only supported by 48% of voters in the first poll taken. Usually that would mean a loss for an initiative. But will this one get pro-lifers so riled up that they turn out in unexpected numbers and win it? Either way, huge political landmine for Schwarzenegger, who is putatively pro-choice but with a pro-life base.
Beth Fouhy from AP reports on the competing drug initiatives, reminding us that this may be the most expensive state campaign in US history. The likely losers? Patients who are the unwilling funders. If the drug companies are that worried, though, consumers have a chance to score a real victory.
Comments